Persistent outpatient hyperglycemia is independently associated with survival, recurrence and malignant degeneration following surgery for hemispheric low grade gliomas

Neurological Research

Volumn 32, Issue 4, 2010, Pages 442-448

  Chaichana, Kaisorn L ^a,b   McGirt, Matthew J ^a,b   Woodworth, Graeme F ^a,b   Datoo, Ghazala ^a,b   Tamargo, Rafael J ^a   Weingart, John ^a,c   Olivi, Alessandro ^a   Brem, Henry ^a,c   Quinones Hinojosa, Alfredo ^a,b  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b Neuro Oncology Surgical Outcomes Research Laboratory   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Hyperglycemia; Low grade gliomas; Malignancy; Recurrence; Survival

Indexed keywords

GLUCOSE; STEROID;

ADULT; ANALYSIS; ARTICLE; ASTROCYTOMA; CRANIOTOMY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; FEMALE; GLIOMA; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; OLIGODENDROGLIOMA; OUTPATIENT; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; TUMOR RECURRENCE;

ADULT; AGED; BLOOD GLUCOSE; BRAIN NEOPLASMS; COMORBIDITY; DIABETES MELLITUS; DISEASE PROGRESSION; FEMALE; GLIOMA; HUMANS; HYPERGLYCEMIA; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NERVE DEGENERATION; SURVIVAL RATE; YOUNG ADULT;

EID: 77952170131     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/174313209X431101     Document Type: Article

References (52)

1. Low-Grade Glioma Guidelines Team in association with the Guidelines and Outcomes Committee of the American Association of Neurological Surgeons. Practice parameters in adults with suspected or known supratentorial nonoptic pathway low-grade gliomas. Neurosurg Focus 1998; 4: e10
2. Eyre HJ, Crowley JJ, Townsend JJ, et al. A randomized trial of radiotherapy versus radiotherapy plus CCNU for incompletely resected low-grade gliomas: A Southwest Oncology Group study. J Neurosurg 1993; 78: 909-914
3. Gannett DE, Wisbeck WM, Silbergeld DL, et al. The role of postoperative irradiation in the treatment of oligodendroglioma. Int J Radiat Oncol Biol Phys 1994; 30: 567-573
4. Leighton C, Fisher B, Bauman G, et al. Supratentorial low-grade glioma in adults: An analysis of prognostic factors and timing of radiation. J Clin Oncol 1997; 15: 1294-1301
5. McCormack BM, Miller DC, Budzilovich GN, et al. Treatment and survival of low-grade astrocytoma in adults - 1977-1988. Neurosurgery 1992; 31: 636-642
6. Philippon JH, Clemenceau SH, Fauchon FH, et al. Supratentorial low-grade astrocytomas in adults. Neurosurgery 1993; 32: 554-559
7. Piepmeier JM. Observations on the current treatment of low-grade astrocytic tumors of the cerebral hemispheres. J Neurosurg 1987; 67: 177-181
8. Shibamoto Y, Kitakabu Y, Takahashi M, et al. Supratentorial low-grade astrocytoma. Correlation of computed tomography findings with effect of radiation therapy and prognostic variables. Cancer 1993; 72: 190-195
9. Lote K, Egeland T, Hager B, et al. Prognostic significance of CT contrast enhancement within histological subgroups of intracranial glioma. J Neurooncol 1998; 40: 161-170
10. Shaw E, Arusell R, Scheithauer B, et al. Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: Initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/ Eastern Cooperative Oncology Group Study. J Clin Oncol 2002; 20: 2267-2276
11. Laws ER, Jr, Taylor WF, Clifton MB, et al. Neurosurgical management of low-grade astrocytoma of the cerebral hemispheres. J Neurosurg 1984; 61: 665-673
12. Berger MS, Deliganis AV, Dobbins J, et al. The effect of extent of resection on recurrence in patients with low grade cerebral hemisphere gliomas. Cancer 1994; 74: 1784-1791
13. North CA, North RB, Epstein JA, et al. Low-grade cerebral astrocytomas. Survival and quality of life after radiation therapy. Cancer 1990; 66: 6-14
14. Smith JS, Chang EF, Lamborn KR, et al. Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas. J Clin Oncol 2008; 26: 1338-1345
15. Krinsley JS. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc 2004; 79: 992-1000
16. Pittas AG, Siegel RD, Lau J. Insulin therapy and in-hospital mortality in critically ill patients: systematic review and metaanalysis of randomized controlled trials. JPEN J Parenter Enteral Nutr 2006; 30: 164-172
17. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 345: 1359-1367
18. Mudespacher D, Radovanovic D, Camenzind E, et al. Admission glycaemia and outcome in patients with acute coronary syndrome. Diab Vasc Dis Res 2007; 4: 346-352
19. McGirt MJ, Woodworth GF, Ali M, et al. Persistent perioperative hyperglycemia as an independent predictor of poor outcome after aneurysmal subarachnoid hemorrhage. J Neurosurg 2007; 107: 1080-1085
20. McGirt MJ, Woodworth GF, Coon AL, et al. Independent predictors of morbidity after image-guided stereotactic brain biopsy: A risk assessment of 270 cases. J Neurosurg 2005; 102: 897-901
21. Woodworth GF, Chaichana KL, McGirt MJ, et al. Predictors of ambulatory function after surgical resection of intramedullary spinal cord tumors. Neurosurgery 2007; 61: 99-105
22. Dang CV, Semenza GL. Oncogenic alterations of metabolism. Trends Biochem Sci 1999; 24: 68-72
23. Jelluma N, Yang X, Stokoe D, et al. Glucose withdrawal induces oxidative stress followed by apoptosis in glioblastoma cells but not in normal human astrocytes. Mol Cancer Res 2006; 4: 319-330
24. Oudard S, Arvelo F, Miccoli L, et al. High glycolysis in gliomas despite low hexokinase transcription and activity correlated to chromosome 10 loss. Br J Cancer 1996; 74: 839-845
25. Warburg O. On the origin of cancer cells. Science 1956; 123: 309-314
26. Kleihues P, Louis DN, Scheithauer BW, et al. The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 2002; 61: 215-225
27. Crooks V, Waller S, Smith T, et al. The use of the Karnofsky Performance Scale in determining outcomes and risk in geriatric outpatients. J Gerontol 1991; 46: M139-M144
28. Preiser JC, Devos P. Clinical experience with tight glucose control by intensive insulin therapy. Crit Care Med 2007; 35 (Suppl. 9): S503-S507
29. McGirt MJ, Woodworth GF, Brooke BS, et al. Hyperglycemia independently increases the risk of perioperative stroke, myocardial infarction, and death after carotid endarterectomy. Neurosurgery 2006; 58: 1066-1073
30. Altman DG. Practical Statistics for Medical Research, London: Chapman and Hall, 1991: pp. 336-355
31. Davis FS. Epidemiology of brain tumors. Expert Rev Anticancer Ther 2007; 7 (Suppl. 12): S3-S6
32. Schiff D, Brown PD, Giannini C. Outcome in adult low-grade glioma: The impact of prognostic factors and treatment. Neurology 2007; 69: 1366-1373
33. Medbery CA, 3rd, Straus KL, Steinberg SM, et al. Low-grade astrocytomas: Treatment results and prognostic variables. Int J Radiat Oncol Biol Phys 1988; 15: 837-841
34. van Veelen ML, Avezaat CJ, Kros JM, et al. Supratentorial low grade astrocytoma: Prognostic factors, dedifferentiation, and the issue of early versus late surgery. J Neurol Neurosurg Psychiatry 1998; 64: 581-587
35. Soffietti R, Chio A, Giordana MT, et al. Prognostic factors in welldifferentiated cerebral astrocytomas in the adult. Neurosurgery 1989; 24: 686-692
36. Pignatti F, van den Bent M, Curran D, et al. Prognostic factors for survival in adult patients with cerebral low-grade glioma. J Clin Oncol 2002; 20: 2076-2084
37. Keles GE, Lamborn KR, Berger MS. Low-grade hemispheric gliomas in adults: A critical review of extent of resection as a factor influencing outcome. J Neurosurg 2001; 95: 735-745
38. Bauman G, Lote K, Larson D, et al. Pretreatment factors predict overall survival for patients with low-grade glioma: A recursive partitioning analysis. Int J Radiat Oncol Biol Phys 1999; 45: 923-929
39. Lote K, Egeland T, Hager B, et al. Survival, prognostic factors, and therapeutic efficacy in low-grade glioma: A retrospective study in 379 patients. J Clin Oncol 1997; 15: 3129-3140
40. Semenza GL, Artemov D, Bedi A, et al. 'The metabolism of tumours': 70 years later. Novartis Found Symp 2001; 240: 251-260
41. Semenza GL, Roth PH, Fang HM, et al. Transcriptional regulation of genes encoding glycolytic enzymes by hypoxiainducible factor 1. J Biol Chem 1994; 269: 23757-23763
42. Zundel W, Schindler C, Haas-Kogan D, et al. Loss of PTEN facilitates HIF-1-mediated gene expression. Genes Dev 2000; 14: 391-396
43. Krone CA, Ely JT. Controlling hyperglycemia as an adjunct to cancer therapy. Integr Cancer Ther 2005; 4: 25-31
44. Nilsen TI, Vatten LJ. Prospective study of colorectal cancer risk and physical activity, diabetes, blood glucose and BMI: Exploring the hyperinsulinaemia hypothesis. Br J Cancer 2001; 84: 417-422
45. Suba Z, Barabas J, Szabo G, et al. Increased prevalence of diabetes and obesity in patients with salivary gland tumors. Diabetes Care 2005; 28: 228
46. Suba Z, Ujpal M. [Correlations of insulin resistance and neoplasms]. Magy Onkol 2006; 50: 127-135
47. Harik SI, LaManna JC. Vascular perfusion and blood-brain glucose transport in acute and chronic hyperglycemia. J Neurochem 1988; 51: 1924-1929
48. Kawai N, Keep RF, Betz AL, et al. Hyperglycemia induces progressive changes in the cerebral microvasculature and blood- brain barrier transport during focal cerebral ischemia. Acta Neurochir Suppl 1998; 71: 219-221
49. Matchar DB, Divine GW, Heyman A, et al. The influence of hyperglycemia on outcome of cerebral infarction. Ann Intern Med 1992; 117: 449-456
50. Voll CL, Auer RN. The effect of postischemic blood glucose levels on ischemic brain damage in the rat. Ann Neurol 1988; 24: 638-646
51. Pittas AG, Siegel RD, Lau J. Insulin therapy for critically ill hospitalized patients: A meta-analysis of randomized controlled trials. Arch Intern Med 2004; 164: 2005-2011
52. McGirt MJ, Chaichana KL, Gathinji M, et al. Persistent outpatient hyperglycemia is independently associated with decreased survival after primary resection of malignant brain astrocytomas. Neurosurgery 2008; 63: 286-291